• 19873 Citations
  • 67 h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

Filter
Comment/debate
2019
4 Citations (Scopus)

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

Bast, R. C., Matulonis, U. A., Sood, A. K., Ahmed, A. A., Amobi, A. E., Balkwill, F. R., Wielgos-Bonvallet, M., Bowtell, D. D. L., Brenton, J. D., Brugge, J. S., Coleman, R. L., Draetta, G. F., Doberstein, K., Drapkin, R. I., Eckert, M. A., Edwards, R. P., Elias, K. M., Ennis, D., Futreal, A., Gershenson, D. M. & 23 others, Greenberg, R. A., Huntsman, D. G., Ji, J. X. Y., Kohn, E. C., Iavarone, C., Lengyel, E. R., Levine, D. A., Lord, C. J., Lu, Z., Mills, G. B., Modugno, F., Nelson, B. H., Odunsi, K., Pilsworth, J. A., Rottapel, R. K., Powell, D. J., Shen, L., Shih, I. M., Spriggs, D. R., Walton, J., Zhang, K., Zhang, R. & Zou, L., Jun 15 2019, In : Cancer. 125, 12, p. 1963-1972 10 p.

Research output: Contribution to journalComment/debate

Ovarian Neoplasms
Poly Adenosine Diphosphate Ribose
Drug Therapy
Platinum
Drug Resistance

Erratum: Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer (Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer (2014) 158(1) (185–197), (S0092867414007247), (10.1016/j.cell.2014.06.003))

Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Wu, C. J., Sadanandam, A., Hu, B., Chang, Q., Chu, G. C., Al-Khalil, R., Jiang, S., Xia, H., Fletcher-Sananikone, E., Lim, C., Horwitz, G. I., Viale, A., Pettazzoni, P. & 10 others, Sanchez, N., Wang, H., Protopopov, A., Zhang, J., Heffernan, T., Johnson, R. L., Chin, L., Wang, Y. A., Draetta, G. & DePinho, R. A., Nov 14 2019, In : Cell. 179, 5, 1 p.

Research output: Contribution to journalComment/debate

Open Access
United States Office of Research Integrity
Somatostatin-Secreting Cells
Pancreatic Neoplasms
Chemical activation
2017
26 Citations (Scopus)

How Much Longer Will We Put Up With 100,000 Cancer Drugs?

Workman, P., Draetta, G. F., Schellens, J. H. M. & Bernards, R., Feb 9 2017, In : Cell. 168, 4, p. 579-583 5 p.

Research output: Contribution to journalComment/debate

Drug Costs
Drug Discovery
Pharmaceutical Preparations
Neoplasms
Therapeutics
2005
Molecular Diagnostic Techniques
Cyclin-Dependent Kinases
Up-Regulation
Technology
Neoplasms